PAZDERNIK, Michal, Dan WICHTERLE, Zhi CHEN, Helena BEDANOVA, Josef KAUTZNER, Vojtech MELENOVSKY, Vladimir KARMAZIN, Ivan MALEK, Peter STIAVNICKY, Ales TOMASEK, Eva OZÁBALOVÁ, Jan KREJČÍ, Andreas WAHLE, Honghai ZHANG, Tomas KOVARNIK and Milan SONKA. Heart rate and early progression of cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis. CLINICAL TRANSPLANTATION. HOBOKEN: WILEY, 2020, vol. 34, No 2, p. 1-9. ISSN 0902-0063. Available from: https://dx.doi.org/10.1111/ctr.13773.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Heart rate and early progression of cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis
Authors PAZDERNIK, Michal (203 Czech Republic, guarantor), Dan WICHTERLE (203 Czech Republic), Zhi CHEN (840 United States of America), Helena BEDANOVA (203 Czech Republic), Josef KAUTZNER (203 Czech Republic), Vojtech MELENOVSKY (203 Czech Republic), Vladimir KARMAZIN (203 Czech Republic), Ivan MALEK (203 Czech Republic), Peter STIAVNICKY (203 Czech Republic), Ales TOMASEK (203 Czech Republic), Eva OZÁBALOVÁ (203 Czech Republic, belonging to the institution), Jan KREJČÍ (203 Czech Republic, belonging to the institution), Andreas WAHLE (840 United States of America), Honghai ZHANG (840 United States of America), Tomas KOVARNIK (203 Czech Republic) and Milan SONKA (203 Czech Republic).
Edition CLINICAL TRANSPLANTATION, HOBOKEN, WILEY, 2020, 0902-0063.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30213 Transplantation
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.863
RIV identification code RIV/00216224:14110/20:00116240
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1111/ctr.13773
UT WoS 000506241700001
Keywords in English beta blocker; cardiac allograft vasculopathy; heart rate; optical coherence tomography
Tags 14110115, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 19/8/2020 12:43.
Abstract
Introduction Heart rate slowing agents are frequently prescribed to manage heart transplant (HTx) patients with the assumption that higher heart rate is a risk factor in cardiovascular disease. Patients and Methods This prospective two-center study investigated early progression of cardiac allograft vasculopathy (CAV) in 116 HTx patients. Examinations by coronary optical coherence tomography and 24-hour ambulatory ECG monitoring were performed both at baseline (1 month after HTx) and during follow-up (12 months after HTx). Results During the first post-HTx year, we observed a significant reduction in the mean coronary luminal area from 9.0 +/- 2.5 to 8.0 +/- 2.4 mm(2) (P < .001), and progression in mean intimal thickness (IT) from 106.5 +/- 40.4 to 130.1 +/- 53.0 mu m (P < .001). No significant relationship was observed between baseline and follow-up mean heart rates and IT progression (R = .02, P = .83; R = -.13, P = .18). We found a mild inverse association between beta-blocker dosage at 12 months and IT progression (R = -.20, P = .035). Conclusion Our study did not confirm a direct association between mean heart rate and progression of CAV. The role of beta blockers warrants further investigation, with our results indicating that they may play a protective role in early CAV development.
PrintDisplayed: 21/8/2024 07:20